MicroRNA miR-371a-3p in serum: A sensitive and specific new biomarker for (testicular) germ cell tumors

被引：0
|
作者：
Zengerling F. [1 ]
机构：
[1] Medikamentöse Tumortherapie, Klinik für Urologie und Kinderurologie, Universitätsklinikum Ulm, Prittwitzstr. 43, Ulm
来源：
Der Onkologe | 2017年 / 23卷 / 5期
关键词：
D O I：
10.1007/s00761-017-0200-3
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：389 / 390
页数：1
相关论文
共 50 条
  • [21] miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy
    Plaza, Ximena Rosas
    van Agthoven, Ton
    Meijer, Coby
    van Vugt, Marcel A. T. M.
    de Jong, Steven
    Gietema, Jourik A.
    Looijenga, Leendert H. J.
    CELLS, 2019, 8 (10)
  • [22] Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors
    Murray, Matthew J.
    Ajithkumar, Thankamma
    Harris, Fiona
    Williams, Rachel M.
    Jalloh, Ibrahim
    Cross, Justin
    Ronghe, Milind
    Ward, Dawn
    Scarpini, Cinzia G.
    Nicholson, James C.
    Coleman, Nicholas
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [23] Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours
    Christian D. Fankhauser
    Ailsa J. Christiansen
    Christian Rothermundt
    Richard Cathomas
    Marian S. Wettstein
    Nico C. Grossmann
    Josias B. Grogg
    Arnoud J. Templeton
    Anita Hirschi-Blickenstorfer
    Anja Lorch
    Silke Gillessen
    Holger Moch
    Joerg Beyer
    Thomas Hermanns
    British Journal of Cancer, 2022, 126 : 1140 - 1144
  • [24] Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours
    Fankhauser, Christian D.
    Christiansen, Ailsa J.
    Rothermundt, Christian
    Cathomas, Richard
    Wettstein, Marian S.
    Grossmann, Nico C.
    Grogg, Josias B.
    Templeton, Arnoud J.
    Hirschi-Blickenstorfer, Anita
    Lorch, Anja
    Gillessen, Silke
    Moch, Holger
    Beyer, Joerg
    Hermanns, Thomas
    BRITISH JOURNAL OF CANCER, 2022, 126 (08) : 1140 - 1144
  • [25] Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer
    Syring, Isabella
    Bartels, Joanna
    Holdenrieder, Stefan
    Kristiansen, Glen
    Mueller, Stefan C.
    Ellinger, Joerg
    JOURNAL OF UROLOGY, 2015, 193 (01): : 331 - 337
  • [26] Plasma miR-371a-3p for detection of non-teratomatous viable germ cell tumor in testicular cancer
    Nappi, L.
    Thi, M.
    Eigl, B. J.
    Lum, A.
    Huntsman, D.
    Martin, C.
    O'Neil, B.
    Khalaf, D. J.
    Chi, K. N.
    Gleave, M. E.
    So, A.
    Black, P.
    Daneshmand, S.
    Nichols, C. R.
    Kollmannsberger, C. K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [27] Re: MicroRNA miR-371a-3p-A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid Editorial Comment
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2018, 199 (05): : 1114 - 1114
  • [28] Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting
    Ye, Fei
    Feldman, Darren R.
    Valentino, Alisa
    So, Rachel
    Bromberg, Maria
    Khan, Shah
    Funt, Samuel A.
    Sheinfeld, Joel
    Solit, David B.
    Pessin, Melissa S.
    Peerschke, Ellinor I.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (08): : 867 - 877
  • [29] Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?
    Belge, Gazanfer
    Dieckmann, Klaus-Peter
    Spiekermann, Meike
    Balks, Thomas
    Bullerdiek, Joern
    EUROPEAN UROLOGY, 2012, 61 (05) : 1068 - 1069
  • [30] Serum miR371a Quantitation for Assessing Tumor Burden in Testicular Germ Cell Tumors
    Kunder, Christian
    Imae, Yoriko
    Srinivas, Sandy
    Fan, Alice C.
    LABORATORY INVESTIGATION, 2018, 98 : 703 - 703
12345